Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mary Pinder-Schenck
CDK4/6 Inhibition Stabilizes Disease in Patients With P16-Null Non-Small Cell Lung Cancer and Is Synergistic With mTOR Inhibition
Oncotarget
Oncology
Related publications
Dual Inhibition of EGFR and mTOR Pathways in Small Cell Lung Cancer
British Journal of Cancer
Cancer Research
Oncology
CDK4/6 Inhibition in Cancer: The Cell Cycle Splicing Connection
Molecular and Cellular Oncology
Cancer Research
Molecular Medicine
Quantitative P16 and ESR1 Methylation in the Peripheral Blood of Patients With Non-Small Cell Lung Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Combining Chemotherapy With Epidermal Growth Factor Receptor Inhibition in Advanced Non-Small Cell Lung Cancer
Therapeutic Advances in Medical Oncology
Oncology
Inhibition of mTOR by Temsirolimus Contributes to Prolonged Survival of Mice With Pleural Dissemination of Non-Small-Cell Lung Cancer Cells
Cancer Science
Cancer Research
Medicine
Oncology
ERK Inhibition Represses Gefitinib Resistance in Non-Small Cell Lung Cancer Cells
Oncotarget
Oncology
Vertical Inhibition of the PI3K/Akt/mTOR Pathway Is Synergistic in Breast Cancer
Oncogenesis
Cancer Research
Molecular Biology
Targeting CDK4/6 in Patients With Cancer
Cancer Treatment Reviews
Medicine
Oncology
Radiology
Nuclear Medicine
Imaging
LSH Interacts With and Stabilizes GINS4 Transcript That Promotes Tumourigenesis in Non-Small Cell Lung Cancer
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology